Wondercel Therapeutics
PrivateLast Round
Series A
Jul 10, 2026
Total Funding Raised
$33.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Wondercel Therapeutics operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series A round in July 2026.
Wondercel Therapeutics is a biotechnology company that develops universal CAR-T cell therapy platforms for the treatment of cancer, organ transplantation, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wondercel Therapeutics Comparables
Compare Wondercel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qihan Biotech | 83% | |
| Allogene Therapeutics | 75% | |
| Legend Biotech | 64% |
For institutional investors. Book with your work email.
Wondercel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 10, 2026 | ||||
| Angel | Feb 10, 2023 |
For institutional investors. Book with your work email.
Wondercel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
| YuanBio Venture Capital | Angel |
| 松禾资本 (Green Pine Capital Partners) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2026
$19.4M round with Oriental Fortune Capital and Green Pine Capital Partners.
For institutional investors. Book with your work email.
Wondercel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wondercel Therapeutics's valuation, stock price, and market status.
Is Wondercel Therapeutics a public or private company?
Wondercel Therapeutics is a private company.
What is the current stock price of Wondercel Therapeutics?
Wondercel Therapeutics is a private company, so its shares have no public market price. Caplight tracks Wondercel Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wondercel Therapeutics worth (valuation)?
Valuation information for Wondercel Therapeutics is not publicly available.
Can I buy Wondercel Therapeutics stock?
Wondercel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wondercel Therapeutics's last funding round?
Wondercel Therapeutics's most recent funding round was Series A on July 10, 2026.
Who are the main investors in Wondercel Therapeutics?
Key investors in Wondercel Therapeutics include Oriental Fortune Capital, YuanBio Venture Capital, 松禾资本 (Green Pine Capital Partners).
Will Wondercel Therapeutics IPO soon?
No public IPO plans have been announced for Wondercel Therapeutics.
How can I track Wondercel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Wondercel Therapeutics's shares on secondary markets.